MedPath
NMPA Approval

Loxoprofen Sodium Oral Solution

国药准字H20253798

April 1, 2025

Drug Information

洛索洛芬钠口服溶液

口服溶液剂

10ml:60mg(按C₁₅H₁₇NaO₃计)

化学药品

April 1, 2025

Company Information

Applicant Company

湖南省长沙市浏阳经济技术开发区百竹路19号

Manufacturing Company

长沙市浏阳经济技术开发区健康大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

洛索洛芬钠口服溶液 - NMPA 批准文号 | MedPath